lifestyle.marketresearchjournals.com

Author: ROCHE DIAGNOSTICS CORPORATION

Roche receives FDA 510(k) clearance for cobas® c703 and cobas® ISE neo, next-generation analytical units enhancing efficiency and capability for laboratories

March 30, 2026
Roche expands mass spectrometry menu to include steroid assays receiving CLIA ‘moderate complexity’ designation

March 18, 2026
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities

December 17, 2025